154379-07-4

Basic information

• Product Name: Carbamic acid, (5-bromo-1,4-dihydro-4-oxo-6-phenyl-2-pyrimidinyl)-, ethyl ester
• CAS NO: 154379-07-4
• Molecular Formula: C13H12BrN3O3
• Molecular Weight: 338.161
• Mol File: 154379-07-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (5-bromo-1,4-dihydro-4-oxo-6-phenyl-2-pyrimidinyl)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (5-bromo-1,4-dihydro-4-oxo-6-phenyl-2-pyrimidinyl)-, ethyl ester(154379-07-4)
• EPA Substance Registry System: Carbamic acid, (5-bromo-1,4-dihydro-4-oxo-6-phenyl-2-pyrimidinyl)-, ethyl ester(154379-07-4)

Safety Data

• Hazardous Substances Data: 154379-07-4(Hazardous Substances Data)

Upstream product

• 1609-47-8 diethyl dicarbonate 
• 56741-95-8 bropirimine 
• 541-41-3 chloroformic acid ethyl ester 

Relevant articles and documents

Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus

This invention relates to methods for treating or preventing hepatitis C virus infections in mammals using Toll-Like Receptor (TLR)7 ligands and prodrugs thereof. More particularly, this invention relates to methods of orally administering a therapeutically effective amount of one or more prodrugs of TLR7 ligands for the treatment or prevention of hepatitis C viral infection. Oral administration of these TLR7 immunomodulating ligands and prodrugs thereof to a mammal provides therapeutically effective amounts and reduced undesirable side effects.